FDA recall, , Moderate risk
South Texas Blood & Tissue Center Apheresis Platelets, Leukocytes Reduced
Apheresis Platelets, Leukocytes Reduced were not tested to verify white blood cell count.
Recall ended Oct 5, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
South Texas Blood & Tissue Center began a recall of Apheresis Platelets, Leukocytes Reduced on September 25, 2025, because these products, labeled as leukocytes reduced, were not tested to verify white blood cell count. The recall was added to the FDA's Enforcement Report and classified on October 5, 2026, and distributed in Texas.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Platelets, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- South Texas Blood & Tissue Center
- Hazard
- Quality testing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 100019
- Recall number
- B-0003-2027
All recalls from South Texas Blood & Tissue Center
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
